Clinical Outcome Using The AnapnoGuard Device
The Use of a Novel Endotracheal Tube and
Airway Management System to Prevent
Complications in Lung Transplantation
Vivian Hernandez-Torres, Robert Ratzlaff, Mathew Thomas, Tathagat Narula, Archer K. Martin
A key component of the perioperative management of lung transplant recipients is the avoidance of airway and pulmonary complications in the immediate postoperative period. The AnapnoGuardTM AG100s (Hospitech Respiration Ltd, Kfar Saba, Israel), a novel endotracheal tube and ventilation management system, holds the potential to assist the care team in attenuating complications related to excessive cuff pressure, subglottic secretions, and endobronchial intubation. In this report, we describe the successful use of the AnapnoGuardTM AG100s system in the postoperative management of a lung transplant recipient.
Clinical Outcome Using the AG Cuffill Device
Detrimental Effects of Filling Laryngotracheal Airways To Excessive Pressure (DEFLATE-P): a quality improvement initiative
SORIN J. BRULL
This quality improvement (QI) project was performed at a single center to determine the incidence of postoperative complications associated with use of cuffed airway devices.
An in vitro and in vivo validation of a novel monitor for intracuff pressure in cuffed endotracheal tubes
Archana S. Ramesh1, Senthil G. Krishna1,2, William T. Denman3 & Joseph D. Tobias
A key component of the perioperative management of lung transplant recipients is the avoidance of airway and pulmonary complications in the immediate postoperative period.
ET Tube Cuff Pressures: Avoiding the Avoidable Airway Disaste
Eric Steffel, NRP, BSEMSA.
You are on scene with your partner performing an intubation. Your partner announces that he sees the tube pass through the cords and almost seamlessly you inflate the cuff with 10 mL of air while he pulls the laryngoscope blade and attaches the bag valve mask (BVM) with end-tidal CO2 (ETCO2).